Get more replies from employers
Send a job-specific resume in minutes.
Xenon Pharmaceuticals Inc. seeks a Senior Manager, Trial Operations to lead Phase 3 clinical trials from startup to closeout, partnering with Clinical Development, Regulatory, and external vendors.
Based in Vancouver, BC, with a hybrid work model and potential remote options for exceptional candidates. This strategic yet hands-on role requires deep clinical operations expertise, strong project management, and ability to drive trial strategy, timelines, budgets, and risk mitigation across global
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 and XEN1720 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are being developed for pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
We are seeking a Senior Manager, Trial Operations to join our team. This is a strategic yet hands-on clinical operations role that is responsible for the successful delivery of Phase 3 clinical trials, overseeing activities from study start-up through closeout. The Senior Manager will partner closely with Clinical Development, Clinical Science, CMC, Regulatory Affairs, and external vendors, to drive trial strategy and execution to ensure high-quality study delivery against the plan.
The role is instrumental in overall vendor selection and management, site feasibility and start-up planning, budget and timeline management, and proactive risk identification and mitigation. The successful candidate will bring deep clinical operations expertise, strong project management and organization capabilities, and a proven ability to lead cross-functional teams and external partners in achieving critical program objectives.
This position reports to the Director, Trial Operations, and will be based out of our Vancouver, BC office. We may consider remote locations for exceptional candidates. This is a Hybrid position requiring a minimum of two onsite days per week.
Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short-& long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions.
Xenon encourages time to rest and re-charge through vacation, personal days, sick days, and an end-of-year company shutdown.
Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees.
Compensation Range: CA$140.7K - CA$178K